Lung Cancer: EGFR Inhibitors with Low Nanomolar Activity against a Therapy-Resistant L858R/T790M/C797S Mutant.
about
Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancerThird-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance.Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors.2-Alkylsulfanyl-4(5)-aryl-5(4)-heteroarylimidazoles: An Overview on Synthetic Strategies and Biological Activity.Pharmacokinetic drug evaluation of osimertinib for the treatment of non-small cell lung cancer.From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors.Third generation EGFR TKIs: current data and future directions.Discovery of EGF Receptor Inhibitors That Are Selective for the d746-750/T790M/C797S Mutant through Structure-Based de Novo Design.C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?
P2860
Q28075704-3208C645-8D58-45EF-9F0B-984D5DBBA5C8Q34550460-75DD74FB-C26A-433A-ADE9-46E7061AB255Q47095218-62403621-DDE6-4A60-BD13-EA1D6B08799FQ47397425-FA2B9DA1-1AE7-43C5-AE87-5D9ACE9C5A68Q47450308-67A2388A-B0D1-4835-AF7D-3B27174C8596Q47646377-F3CD3790-8A5B-403D-BB8E-0C8745C1D71CQ49887956-05C87926-FDCA-4B69-8914-7C7FDDEABE4EQ53111572-D9389534-D6C8-42E9-81EC-E58246944F6BQ57174988-74125F33-6366-47A2-A024-41D1CADB9C27
P2860
Lung Cancer: EGFR Inhibitors with Low Nanomolar Activity against a Therapy-Resistant L858R/T790M/C797S Mutant.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lung Cancer: EGFR Inhibitors w ...... tant L858R/T790M/C797S Mutant.
@en
Lung Cancer: EGFR Inhibitors w ...... tant L858R/T790M/C797S Mutant.
@nl
type
label
Lung Cancer: EGFR Inhibitors w ...... tant L858R/T790M/C797S Mutant.
@en
Lung Cancer: EGFR Inhibitors w ...... tant L858R/T790M/C797S Mutant.
@nl
prefLabel
Lung Cancer: EGFR Inhibitors w ...... tant L858R/T790M/C797S Mutant.
@en
Lung Cancer: EGFR Inhibitors w ...... tant L858R/T790M/C797S Mutant.
@nl
P2093
P2860
P356
P1476
Lung Cancer: EGFR Inhibitors w ...... stant L858R/T790M/C797S Mutant
@en
P2093
Gerhard Kelter
Heiner Fiebig
Marcel Günther
Michael Juchum
P2860
P304
10890-10894
P356
10.1002/ANIE.201603736
P407
P577
2016-07-28T00:00:00Z